AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17058239 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (50 mg/6 h)
Number of subjects: 25
Study 17058239 — intervention group
Group type: COMPARATOR
Intervention: No treatment with steroids
Number of subjects: 25
Study 12629535 — intervention group
Group type: EXPERIMENTAL
Intervention: GTS‐21 (25, 75 and 150 mg)
Number of subjects: 18
Study 12629535 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 10853877 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose ATP infusion (25-40 microg kg(‐1) min(‐1))
Number of subjects: 28
Study 10853877 — intervention group
Group type: EXPERIMENTAL
Intervention: Middle-dose ATP infusion (45-60 microg kg(‐1) min(‐1))
Number of subjects: 28
Study 10853877 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose ATP infusion (65-75 microg kg(‐1) min(‐1))
Number of subjects: 28
Study 9165960 — intervention group
Group type: EXPERIMENTAL
Intervention: rocuronium 0.6 mg.kg‐1
Number of subjects: 81
Study 9165960 — intervention group
Group type: EXPERIMENTAL
Intervention: rocuronium
Number of subjects: 81
Study 8465356 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical, laboratory, radiological, and electrocardiographic findings
Number of subjects: 3127
Study 8465356 — intervention group
Group type: EXPERIMENTAL
Intervention: Age > 65 years, male sex, dysarthria, multiple attacks, diabetes, angina pectoris, intermittent claudication, CT evidence of cerebral infarct, ECG evidence of anteroseptal infarct, ST depression, left ventricular hypertrophy, left atrial conduction delay
Number of subjects: 3127
Study 8465356 — intervention group
Group type: EXPERIMENTAL
Intervention: Monocular attacks only or presence of rotatory dizziness
Number of subjects: 3127
Study 3839973 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate (6 g per day)
Number of subjects: 23
Study 3839973 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 3839973 — intervention group
Group type: EXPERIMENTAL
Intervention: Open sucralfate treatment (after initial placebo)
Number of subjects: 23
Study 30999870 — intervention group
Group type: EXPERIMENTAL
Intervention: MOVI-da10-Enriched! intervention (n=3 schools)
Number of subjects: 900
Study 30999870 — intervention group
Group type: EXPERIMENTAL
Intervention: MOVI-da10-Standard! intervention (n=2 schools)
Number of subjects: 900
Study 30999870 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=3 schools)
Number of subjects: 900
Study 28653394 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranolazine
Number of subjects: 16
Study 28653394 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 27515331 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioabsorbable cardiac matrix (BCM)
Number of subjects: 303
Study 27515331 — intervention group
Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 303
Study 24316240 — intervention group
Group type: EXPERIMENTAL
Intervention: Fit and Strong! Plus (PA and weight management)
Number of subjects: 400
Study 24316240 — intervention group
Group type: COMPARATOR
Intervention: Fit and Strong! (PA only)
Number of subjects: 400
Study 22543981 — intervention group
Group type: EXPERIMENTAL
Intervention: ADRB1 Arg389 carriers
Number of subjects: 140
Study 22543981 — intervention group
Group type: EXPERIMENTAL
Intervention: ADRB2 Arg16Gly carriers
Number of subjects: 140
Study 22543981 — intervention group
Group type: EXPERIMENTAL
Intervention: ADRB2 Arg16/Gln27 carriers
Number of subjects: 140
Study 22543981 — intervention group
Group type: EXPERIMENTAL
Intervention: eNOS 894GG carriers
Number of subjects: 140
Study 22543981 — intervention group
Group type: EXPERIMENTAL
Intervention: eNOS 894GT carriers
Number of subjects: 140
Study 20196185 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine XR (extended release quetiapine fumarate)
Number of subjects: 0
Study 20196185 — intervention group
Group type: COMPARATOR
Intervention: Quetiapine IR (immediate release quetiapine)
Number of subjects: 0
Study 18655973 — intervention group
Group type: EXPERIMENTAL
Intervention: Wavefront parameters alone (WF, n = 11)
Number of subjects: 14
Study 18655973 — intervention group
Group type: EXPERIMENTAL
Intervention: Wavefront combined with topography values (WF&VP, n = 10)
Number of subjects: 14
Study 15197544 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 1499
Study 15197544 — intervention group
Group type: EXPERIMENTAL
Intervention: Free estradiol index (FEI)
Number of subjects: 1499
Study 15197544 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip BMD
Number of subjects: 1499
Study 15197544 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative ultrasound (QUS) measures
Number of subjects: 1499
Study 12810993 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine (3 mg/kg/day, increased to 4 mg/kg after two weeks if response was inadequate)
Number of subjects: 30
Study 12810993 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (0.5 mg/kg weekly)
Number of subjects: 30
Study 10577636 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirofiban
Number of subjects: 2222
Study 8913901 — intervention group
Group type: EXPERIMENTAL
Intervention: St. Louis University coding rules for ECG classification
Number of subjects: 4244
Study 8913901 — intervention group
Group type: COMPARATOR
Intervention: Standard MC criteria for ECG classification
Number of subjects: 4244
Study 1862891 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular ketorolac tromethamine (30 mg)
Number of subjects: 85
Study 1862891 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular morphine (10 mg)
Number of subjects: 85
Study 1862891 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study 6349780 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery followed by adjuvant chemotherapy (5-FU and methyl-CCNU)
Number of subjects: 312
Study 6349780 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone (Control)
Number of subjects: 312
Study 31911524 — intervention group
Group type: EXPERIMENTAL
Intervention: POPQ-based surgery
Number of subjects: 0
Study 31911524 — intervention group
Group type: COMPARATOR
Intervention: Simulated apical support-based surgery
Number of subjects: 0
Study 31204040 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy group (intraoral cryotherapy application for 5 minutes after IANB)
Number of subjects: 104
Study 31204040 — intervention group
Group type: COMPARATOR
Intervention: Control group (IANB injection with 2% lidocaine)
Number of subjects: 104
Study 27982750 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcript plus video evidence with a judicial warning
Number of subjects: 60
Study 27982750 — intervention group
Group type: EXPERIMENTAL
Intervention: Video evidence with a judicial warning
Number of subjects: 60
Study 27982750 — intervention group
Group type: COMPARATOR
Intervention: Transcript evidence
Number of subjects: 60
Study 25730446 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical honey gel
Number of subjects: 28
Study 25730446 — intervention group
Group type: COMPARATOR
Intervention: Conventional eardrops
Number of subjects: 28
Study 23522754 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel node biopsy (SNB) procedure in multifocal breast cancer patients
Number of subjects: 1026
Study 23522754 — intervention group
Group type: COMPARATOR
Intervention: Sentinel node biopsy (SNB) procedure in unifocal breast cancer patients
Number of subjects: 1026
Study 23522754 — intervention group
Group type: EXPERIMENTAL
Intervention: Further nodal involvement after a positive sentinel node in multifocal breast cancer patients
Number of subjects: 1026
Study 23522754 — intervention group
Group type: COMPARATOR
Intervention: Further nodal involvement after a positive sentinel node in unifocal breast cancer patients
Number of subjects: 1026
Study 22115144 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental friendship coaching (PFC) - a 3-month parent training intervention targeting peer relationships of children with ADHD
Number of subjects: 62
Study 22115144 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 62
Study 22115144 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental friendship coaching (PFC)
Number of subjects: 62
Study 19556358 — intervention group
Group type: EXPERIMENTAL
Intervention: Follicular phase (days 6-12)
Number of subjects: 9
Study 19556358 — intervention group
Group type: COMPARATOR
Intervention: Luteal phase (days 18-24)
Number of subjects: 9
Study 17402274 — intervention group
Group type: EXPERIMENTAL
Intervention: Trandolapril 2 mg once daily for 8 weeks
Number of subjects: 120
Study 17402274 — intervention group
Group type: COMPARATOR
Intervention: Enalapril 5 mg once daily for 8 weeks
Number of subjects: 120
Study 17402274 — intervention group
Group type: EXPERIMENTAL
Intervention: Trandolapril 2 mg once daily
Number of subjects: 120
Study 17402274 — intervention group
Group type: COMPARATOR
Intervention: Enalapril 5 mg once daily
Number of subjects: 120
Study 17402274 — intervention group
Group type: EXPERIMENTAL
Intervention: Trandolapril
Number of subjects: 120
Study 17402274 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 120
Study 15613923 — intervention group
Group type: EXPERIMENTAL
Intervention: FoodState Vitamin C complex (500 mg vitamin C, 160 mg bioflavonoids, 600 mg magnesium and 900 mg vitamin B complex)
Number of subjects: 25
Study 15613923 — intervention group
Group type: EXPERIMENTAL
Intervention: FoodState Vitamin C complex
Number of subjects: 25
Study 11412255 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy
Number of subjects: 457
Study 11412255 — intervention group
Group type: COMPARATOR
Intervention: Control (non-irradiated patients)
Number of subjects: 457
Study 9150780 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 1 mg.kg‐1
Number of subjects: 104
Study 9150780 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 0.5 mg.kg‐1
Number of subjects: 104
Study 9150780 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 0.5 mg.kg‐1, 1 mg.kg‐1, and 2 mg.kg‐1
Number of subjects: 104
Study 9150780 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 104
Study 7715467 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen-gestagen replacement therapy
Number of subjects: 2322
Study 3233896 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous push method
Number of subjects: 155
Study 3233896 — intervention group
Group type: COMPARATOR
Intervention: Intravenous piggyback method
Number of subjects: 155
Study 31397124 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal acupoints along meridian plus exercising combined with penetration needling on yang meridians of back
Number of subjects: 60
Study 31397124 — intervention group
Group type: COMPARATOR
Intervention: Simple penetration needling on yang meridians of back
Number of subjects: 60
Study 28454590 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP of 12 cmH2O with lung recruitment maneuvers (high PEEP)
Number of subjects: 2013
Study 28454590 — intervention group
Group type: COMPARATOR
Intervention: PEEP of 4 cmH2O without recruitment maneuvers (low PEEP)
Number of subjects: 2013
Study 25411207 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi Qigong training (1.5 h/session; 4 sessions/week for 6 months)
Number of subjects: 52
Study 25411207 — intervention group
Group type: COMPARATOR
Intervention: No training (control group, n = 27)
Number of subjects: 52
Study 23669515 — intervention group
Group type: EXPERIMENTAL
Intervention: FITNET (Internet-based cognitive behavioral therapy)
Number of subjects: 112
Study 23669515 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 112
Study 23669515 — intervention group
Group type: EXPERIMENTAL
Intervention: FITNET
Number of subjects: 112
Study 21989146 — intervention group
Group type: EXPERIMENTAL
Intervention: LOAD-10 therapy (levofloxacin 250 mg, omeprazole 40 mg, nitazoxanide 500 mg twice daily, doxycycline 100 mg) for 10 days
Number of subjects: 180
Study 21989146 — intervention group
Group type: EXPERIMENTAL
Intervention: LOAD-7 therapy (levofloxacin 250 mg, omeprazole 40 mg, nitazoxanide 500 mg twice daily, doxycycline 100 mg) for 7 days
Number of subjects: 180
Study 21989146 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined LOAD therapies
Number of subjects: 180
Study 21989146 — intervention group
Group type: COMPARATOR
Intervention: LAC therapy (lansoprazole 30 mg, amoxicillin 1 g, clarithromycin 500 mg) for 10 days
Number of subjects: 180
Study 18087212 — intervention group
Group type: EXPERIMENTAL
Intervention: bi-layer composite membrane
Number of subjects: 18
Study 18087212 — intervention group
Group type: EXPERIMENTAL
Intervention: bi-layer composite membrane with moisturizer
Number of subjects: 18
Study 18087212 — intervention group
Group type: COMPARATOR
Intervention: bi-layer composite membrane after moisturizer application
Number of subjects: 18
Study 16470745 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel, 200 mg/m² IV, every 21 days for a minimum of four cycles
Number of subjects: 45
Study 16470745 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 45
Study 15347717 — intervention group
Group type: EXPERIMENTAL
Intervention: V/Q lung scintigraphy in SPECT technique
Number of subjects: 83
Study 15347717 — intervention group
Group type: COMPARATOR
Intervention: Planar V/Q scintigraphy
Number of subjects: 83
Study 15347717 — intervention group
Group type: COMPARATOR
Intervention: Multislice spiral CT
Number of subjects: 83
Study 11588321 — intervention group
Group type: EXPERIMENTAL
Intervention: abciximab (0.25 mg/kg bolus before the lesion was crossed with guidewire and 0.125 micro. kg(‐1). min(‐1) infusion for 12 hours)
Number of subjects: 151
Study 11588321 — intervention group
Group type: COMPARATOR
Intervention: Control (no abciximab)
Number of subjects: 151
Study 9849555 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol A (without immediate access to laboratory tests)
Number of subjects: 0
Study 9849555 — intervention group
Group type: COMPARATOR
Intervention: Protocol B (with immediate access to laboratory tests)
Number of subjects: 0
Study 7862710 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (0.01, 0.1, 1.0 mg/70 kg)
Number of subjects: 0
Study 7862710 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (1.0, 3.0, 10 mg/70 kg)
Number of subjects: 0
Study 7862710 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide (30% in oxygen)
Number of subjects: 0
Study 7862710 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 0
Study 7862710 — intervention group
Group type: COMPARATOR
Intervention: 100% oxygen placebo
Number of subjects: 0
Study 2512175 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhein (diacetyl‐rhein 50 mg b.d. for 5 days)
Number of subjects: 12
Study 2512175 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31979255 — intervention group
Group type: EXPERIMENTAL
Intervention: FMS‐based afterschool program (n = 20)
Number of subjects: 31
Study 31979255 — intervention group
Group type: COMPARATOR
Intervention: Traditional afterschool program (n = 11)
Number of subjects: 31
Study 31404683 — intervention group
Group type: EXPERIMENTAL
Intervention: Real Acupuncture
Number of subjects: 56
Study 31404683 — intervention group
Group type: EXPERIMENTAL
Intervention: Real Dipyrone
Number of subjects: 56
Study 31404683 — intervention group
Group type: COMPARATOR
Intervention: Placebo Acupuncture
Number of subjects: 56
Study 31404683 — intervention group
Group type: COMPARATOR
Intervention: Placebo Dipyrone
Number of subjects: 56
Study 28323084 — intervention group
Group type: EXPERIMENTAL
Intervention: HospBLS
Number of subjects: 122
Study 26562297 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (labeled as 'person'/'child with epilepsy')
Number of subjects: 425
Study 26562297 — intervention group
Group type: COMPARATOR
Intervention: Group B (labeled as 'epileptic'/'epileptic child')
Number of subjects: 425
Study 22820956 — intervention group
Group type: EXPERIMENTAL
Intervention: Postbariatric abdominoplasty (20 patients)
Number of subjects: 32
Study 22820956 — intervention group
Group type: COMPARATOR
Intervention: Control group (12 patients waiting for abdominoplasty)
Number of subjects: 32
Study 20947068 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine infusion
Number of subjects: 15
Study 20947068 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 15
Study 18948149 — intervention group
Group type: EXPERIMENTAL
Intervention: Crime context with accomplices
Number of subjects: 100
Study 18948149 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral context with accomplices
Number of subjects: 100
Study 18948149 — intervention group
Group type: EXPERIMENTAL
Intervention: Crime context with innocents
Number of subjects: 100
Study 18948149 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral context with innocents
Number of subjects: 100
Study 18948149 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 100
Study 17170650 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical diclofenac sodium
Number of subjects: 0
Study 17170650 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 15220879 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-contact dynamic compression plating (LC-DCP)
Number of subjects: 0
Study 15220879 — intervention group
Group type: COMPARATOR
Intervention: Dynamic compression plating (DCP)
Number of subjects: 0
Study 11417145 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid Self-Hypnosis (RSH)
Number of subjects: 0
Study 11417145 — intervention group
Group type: COMPARATOR
Intervention: Hypnosis Induction Profile (HIP)
Number of subjects: 0
Study 9248252 — intervention group
Group type: EXPERIMENTAL
Intervention: Photorefractive keratectomy (PRK)
Number of subjects: 14
Study 8257478 — intervention group
Group type: EXPERIMENTAL
Intervention: 5'-MTHF (50 mg/day p.o.)
Number of subjects: 96
Study 8257478 — intervention group
Group type: COMPARATOR
Intervention: Trazodone (100 mg/day p.o.)
Number of subjects: 96
Study 3582469 — intervention group
Group type: EXPERIMENTAL
Intervention: Urapidil infusion at 10 mg/h for 4 h
Number of subjects: 12
Study 3582469 — intervention group
Group type: EXPERIMENTAL
Intervention: Urapidil infusion at 2.5 mg/h for 4 h
Number of subjects: 12
Study 3582469 — intervention group
Group type: EXPERIMENTAL
Intervention: Urapidil infusion at 5 mg/h for 4 h
Number of subjects: 12
Study 3582469 — intervention group
Group type: EXPERIMENTAL
Intervention: Urapidil infusion at 10 mg/h followed by a 60 mg capsule after 2 h
Number of subjects: 12
Study 29360843 — intervention group
Group type: EXPERIMENTAL
Intervention: Speaking (counting loudly and repeatedly from one to ten)
Number of subjects: 0
Study 29360843 — intervention group
Group type: EXPERIMENTAL
Intervention: Thinking (mentally counting repeatedly from one to ten)
Number of subjects: 0
Study 29360843 — intervention group
Group type: COMPARATOR
Intervention: Listening (listening to verbal counting from one to ten)
Number of subjects: 0
Study 29360843 — intervention group
Group type: COMPARATOR
Intervention: Control (no perturbation)
Number of subjects: 0
Study 26135499 — intervention group
Group type: EXPERIMENTAL
Intervention: E-learning module
Number of subjects: 39
Study 26135499 — intervention group
Group type: COMPARATOR
Intervention: Near-peer tutorial
Number of subjects: 39
Study 26161535 — intervention group
Group type: EXPERIMENTAL
Intervention: ALMANACH
Number of subjects: 1465
Study 26161535 — intervention group
Group type: COMPARATOR
Intervention: Standard practice (control)
Number of subjects: 1465
Study 23176073 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg rasagiline
Number of subjects: 109
Study 23176073 — intervention group
Group type: COMPARATOR
Intervention: 1.5 mg pramipexole
Number of subjects: 109
Study 23176073 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg rasagiline and 1.5 mg pramipexole
Number of subjects: 109
Study 20885016 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentazocine 0.5 mg·kg(‐1) 5 min prior to fentanyl
Number of subjects: 277
Study 20885016 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal saline (Group II)
Number of subjects: 277
Study 20885016 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Group I)
Number of subjects: 277
Study 18979582 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiber mixture
Number of subjects: 97
Study 18979582 — intervention group
Group type: COMPARATOR
Intervention: Lactulose
Number of subjects: 97
Study 16492133 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based program to teach facial affect identification
Number of subjects: 10
Study 14561116 — intervention group
Group type: EXPERIMENTAL
Intervention: Event-related brain potentials assessing attentional processes
Number of subjects: 0
Study 14561116 — intervention group
Group type: EXPERIMENTAL
Intervention: Event-related brain potentials assessing working-memory processes
Number of subjects: 0
Study 14561116 — intervention group
Group type: EXPERIMENTAL
Intervention: Event-related brain potentials assessing attention to gender
Number of subjects: 0
Study 10765090 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 3040
Study 10765090 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3040
Study 8776692 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard osmolality feeding (1200 mOsmol/L)
Number of subjects: 36
Study 8776692 — intervention group
Group type: EXPERIMENTAL
Intervention: High osmolality feeding (1700 mOsmol/L)
Number of subjects: 36
Study 8776692 — intervention group
Group type: COMPARATOR
Intervention: Overall results for all lines
Number of subjects: 36
Study 1626958 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotretinoin (approximately 0.14 mg/kg per day for 3 years)
Number of subjects: 269
Study 1626958 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 269
Study 6437509 — intervention group
Group type: EXPERIMENTAL
Intervention: Loperamide 0.8 mg/kg/24 h
Number of subjects: 315
Study 6437509 — intervention group
Group type: EXPERIMENTAL
Intervention: Loperamide 0.4 mg/kg/24 h
Number of subjects: 315
Study 6437509 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus oral rehydration therapy
Number of subjects: 315
Study 31348840 — intervention group
Group type: EXPERIMENTAL
Intervention: HEMOBLAST (HB) hemostatic powder
Number of subjects: 24
Study 29421020 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow oxygen (10-15 L/min)
Number of subjects: 124
Study 29421020 — intervention group
Group type: COMPARATOR
Intervention: Room air
Number of subjects: 124
Study 26760454 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced contact protocol for 12 months
Number of subjects: 1838